1. Home
  2. SELF vs SCLX Comparison

SELF vs SCLX Comparison

Compare SELF & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Self Storage Inc.

SELF

Global Self Storage Inc.

HOLD

Current Price

$5.33

Market Cap

57.0M

Sector

Real Estate

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$5.91

Market Cap

52.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SELF
SCLX
Founded
1983
2011
Country
United States
United States
Employees
N/A
30
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.0M
52.9M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
SELF
SCLX
Price
$5.33
$5.91
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
27.5K
34.1K
Earning Date
05-08-2026
04-10-2026
Dividend Yield
5.41%
N/A
EPS Growth
N/A
N/A
EPS
0.18
N/A
Revenue
$12,705,245.00
N/A
Revenue This Year
$3.04
$122.52
Revenue Next Year
$3.47
$186.30
P/E Ratio
$29.78
N/A
Revenue Growth
1.40
N/A
52 Week Low
$4.73
$3.60
52 Week High
$5.83
$34.27

Technical Indicators

Market Signals
Indicator
SELF
SCLX
Relative Strength Index (RSI) 57.92 35.17
Support Level $5.12 $4.56
Resistance Level $5.31 $7.76
Average True Range (ATR) 0.12 0.66
MACD 0.02 -0.01
Stochastic Oscillator 81.82 53.09

Price Performance

Historical Comparison
SELF
SCLX

About SELF Global Self Storage Inc.

Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: